Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.6 USD | -10.03% | -21.21% | +161.96% |
Apr. 18 | JonesTrading Starts Rezolute With Buy Rating, $10 Price Target | MT |
Mar. 06 | Rezolute, Inc. Reports Validation of the Potential Use of RZ358 for Treatment of Non-Islet Cell Tumor Hypoglycemia | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+161.96% | 104M | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.84% | 22.02B | |
-17.84% | 20.9B | |
-9.37% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- RZLT Stock
- News Rezolute, Inc.
- Sector Update: Health Care Stocks Fade Late, Finish in the Red